High systemic immune-inflammation index predicts poor prognosis in advanced lung adenocarcinoma patients treated with EGFR-TKIs

EGFR-TKIs have been widely used in the first-line treatment of NSCLC patients harboring EGFR mutations. However, the prognosis indicators are limited. In the present study, the prognostic value of systemic immune-inflammation index (SII), neutrophil to lymphocyte ratio (NLR), and platelet to lymphoc...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Chao, Zhang, Na, Wang, Yapeng, Jiang, Shun, Lu, Min, Huang, Yan, Ma, Jin’an, Hu, Chunhong, Hou, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831201/
https://www.ncbi.nlm.nih.gov/pubmed/31415428
http://dx.doi.org/10.1097/MD.0000000000016875

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831201/
https://www.ncbi.nlm.nih.gov/pubmed/31415428
http://dx.doi.org/10.1097/MD.0000000000016875

Ejemplares similares